GRNA Insider Trading Activity and SEC Form 4 Filings
GRNA insider trading summary
No open-market insider purchases or sales of GreenLight Biosciences Holdings, PBC (GRNA) have been reported on SEC Form 4 in the past 12 months.
Latest GRNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 20, 2023 | Cormorant Asset Management, LP | Insider | Sell | $0 (9,188,659 @ $0.00) |
| Jul 20, 2023 | Cormorant Global Healthcare Master Fund, LP | Insider | Sell | $0 (9,188,659 @ $0.00) |
| Jul 20, 2023 | Cormorant Private Healthcare Fund II, LP | Insider | Sell | $0 (9,188,659 @ $0.00) |
| Jul 20, 2023 | Bihua Chen | Insider | Sell | $0 (9,188,659 @ $0.00) |
| Aug 11, 2022 | Builders Vision, LLC | 10% Owner | Buy | $25.0M (6,377,551 @ $3.92) |
| Aug 11, 2022 | Morningside Venture Investments Ltd | 10% Owner | Buy | $12.0M (3,061,224 @ $3.92) |
| Aug 11, 2022 | Builders Vision, LLC | 10% Owner | Buy | $500K (127,551 @ $3.92) |
| Aug 11, 2022 | Matthew Allen Walker | Director | Buy | $250K (63,775 @ $3.92) |
| Aug 11, 2022 | Matthew Allen Walker | Director | Buy | $25.0M (6,377,551 @ $3.92) |
| Feb 2, 2022 | Eric OBrien | Director | Buy | $7.0M (700,000 @ $10.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.